NIH Locks Doors for Secret Antiviral Biodefense Contract Reviews
Published Date: 5/15/2025
Notice
Summary
The National Institute of Allergy and Infectious Diseases is holding a secret meeting from June 3-5, 2025, to review special contract proposals about fighting dangerous infections and viruses. This closed meeting protects private info and trade secrets while deciding which projects get funding. Scientists and companies working on new medical defenses should watch for updates, as this could impact future research money and timelines.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
Closed Meeting to Protect Trade Secrets
The NIAID meeting is closed under 5 U.S.C. §§ 552b(c)(4) and 552b(c)(6) because contract proposals and discussions could disclose confidential trade secrets, commercial property (such as patentable material), and personal information. The closure is intended to prevent disclosure that would be a clearly unwarranted invasion of personal privacy.
NIAID Reviewing Contract Proposals June 3–5
From June 3 through June 5, 2025, 9:00 a.m. to 5:00 p.m., the NIAID Special Emphasis Panel will meet at Rocky Mountain Laboratories (903 S Fourth St., Hamilton, MT) with a virtual option to review and evaluate contract proposals for Medical Countermeasures for Biodefense and Emerging Infectious Diseases Research and Direct Acting Antivirals (DAA). Contact listed is Kristin L. McNally, Ph.D., Scientific Review Officer.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13802 — Government Owned Invention Available for License: Generating Conditional and Reverse Conditional Loss-of-Function Alleles in Mouse Casq2
The National Institutes of Health is offering special mouse strains that help study a rare heart rhythm disorder called CPVT. These mice let scientists explore how a key heart gene works and test new gene therapies. Researchers interested in this tool can access it now—no patents, just pure science ready to speed up discoveries!
2026-13612 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review and decide on important health research grant applications. These meetings keep sensitive info private to protect personal and commercial secrets. Researchers applying for grants and the public can expect no changes in funding timing or amounts, just careful, confidential reviews.
2026-13480 — Government Owned Invention Available for License: A Conserved Viral Peptide for Use in Cancer Immunotherapy
The National Cancer Institute has created a special viral peptide that could help prevent and treat a serious liver cancer called HCC. This new discovery might lead to a vaccine or therapy that boosts the immune system to fight cancer better. Researchers and companies interested in developing this treatment can now license the technology, opening doors for faster progress and potential health benefits worldwide.
2026-13479 — Government Owned Invention Available for License: Chimeric VLP Vaccines To Prevent HTLV-1 Infection
The National Cancer Institute has created a new vaccine to stop HTLV-1, a virus that can cause serious diseases like leukemia. Right now, no vaccine exists, so this invention could protect millions, especially in underserved areas. They’re looking for partners to help develop and license this promising vaccine, which could save lives and reduce healthcare costs in the near future.
2026-13337 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on July 24, 2026, to review and evaluate important grant applications related to cancer, imaging, eye diseases, and reproductive health. These meetings protect private info and trade secrets, so they’re not open to the public. Researchers and organizations applying for grants should note the dates as these reviews impact funding decisions.
2026-13311 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review grant applications and contract proposals. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants or contracts should watch these dates closely, as funding decisions could impact their projects and budgets.
Previous / Next Documents
Previous: 2025-08654 — EONY Generation Limited; Notice of Reasonable Period of Time for Water Quality Certification Application
EONY Generation Limited asked New York DEC for permission to make sure their project won’t harm water quality. New York DEC has one year, until May 2, 2026, to decide. If they don’t act by then, their say is waived, so EONY can move forward without delay.
Next: 2025-08656 — Proposed Information Collection Activity; Generic Clearance for Disaster Information Collection Forms
The Administration for Children and Families wants to keep using their disaster info forms for three more years without changing them. This helps them keep collecting important disaster data smoothly. No new costs or big changes are coming, so everyone involved can keep doing their jobs without a hitch.